医院感染控制市场规模、份额和成长分析(按产品、应用、技术、疾病、最终用户和地区划分)—产业预测(2026-2033 年)
市场调查报告书
商品编码
1896915

医院感染控制市场规模、份额和成长分析(按产品、应用、技术、疾病、最终用户和地区划分)—产业预测(2026-2033 年)

Hospital-Acquired Infection Control Market Size, Share, and Growth Analysis, By Product, By Application, By Technology, By Disease, By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年,医院感染控制市场规模将达到 326.2 亿美元,到 2025 年将达到 350 亿美元,到 2033 年将达到 615 亿美元,在预测期(2026-2033 年)内,复合年增长率为 7.3%。

医院感染控制市场正经历显着成长,这主要得益于人们对预防交叉感染重要性的认识不断提高,以及医疗机构感染疾病发生率居高不下。政府对感染控制倡议的支持也对市场动态起到了关键作用。各级医疗机构制定的严格感染预防标准和通讯协定,营造了以安全和卫生为中心的文化。此外,先进监测解决方案的日益普及也强化了这一趋势,使医疗机构能够实施积极主动的策略,有效预防和控制医院感染。这些因素共同促成了医院在维护病人安全和改善整体健康结果方面日益增强的投入。

医院感染控制市场驱动因素

全球医院感染控制市场正经历显着成长,主要受每年手术量增加的推动。这一增长归因于多种因素,包括肥胖症和其他需要手术治疗的文明病发生率的上升。随着手术量的增加,医院感染的风险也随之增加,凸显了有效感染控制的迫切需求。因此,医疗机构正在增加对先进感染预防解决方案的投资,以提高病患安全并改善病患的整体治疗效果。

限制医院感染控制市场的因素

随着医疗机构越来越多地选择对可重复使用的医疗设备进行再处理以降低成本和减少废弃物,医院感染控制市场面临挑战。这种做法适用于多种器械,包括手术钳、内视镜和听诊器。儘管再处理具有经济和环境效益,但人们仍对再处理器械的安全性和有效性感到担忧。这些担忧可能导致医护人员和病患犹豫不决,进而影响医疗机构感染控制措施的整体实施。因此,人们对再处理相关风险的认知可能会限制市场成长和感染预防策略的创新。

医院感染控制市场趋势

医院感染预防市场的一大趋势是环氧乙烷灭菌技术的重新应用。该技术具有无与伦比的有效性,尤其适用于对温度敏感的医疗器材。环氧乙烷灭菌技术的復兴源于对能够维持精密设备完整性的先进灭菌方法的需求不断增长。然而,人们对环氧乙烷暴露相关健康风险的认识也显着提高,这迫使医疗机构加强安全措施并采用新技术。随着医院在有效性和安全性之间寻求平衡,预计输送系统和监测方法的创新将提升环氧乙烷在感染预防策略中的吸引力和接受度。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 一手和二手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2025)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析

全球医院感染控制市场规模(按产品和复合年增长率划分)(2026-2033 年)

  • 保护屏障
  • 无菌
  • 消毒剂
    • 产品
    • 干洗手剂
    • 表面消毒剂
    • 皮肤消毒剂
    • 器械消毒剂
    • 配方
    • 液体消毒剂
    • 消毒纸巾
    • 消毒喷雾
  • 消毒器
  • 内视镜再处理产品
  • 其他的

全球医院感染控制市场规模(按应用及复合年增长率划分)(2026-2033 年)

  • 疾病检测
  • 抗药性检测

全球医院感染控制市场规模(依技术及复合年增长率划分)(2026-2033 年)

  • 表型法
  • 基因分型方法

全球医院感染控制市场规模:依疾病及复合年增长率划分(2026-2033 年)

  • 院内肺炎
  • 血液感染疾病
  • 手术部位感染
  • 胃肠道感染疾病
  • 尿道感染
  • 其他的

全球医院感染控制市场规模(按最终用户和复合年增长率划分)(2026-2033 年)

  • 医院/加护病房(ICU)
  • 门诊手术及诊断中心
  • 安养院及妇产中心
  • 其他的

全球医院感染控制市场规模及复合年增长率(2026-2033)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • GCC
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2025 年)
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

    主要企业简介

    • 3M公司(美国)
    • 贝克顿·迪金森公司(BD)(美国)
    • 生物梅里埃公司(法国)
    • Ecolab Inc.(美国)
    • Getinge AB(瑞典)
    • 先进灭菌产品(ASP)(美国)
    • Belimed AG(瑞士)
    • 马塔查纳集团(西班牙)
    • MMM集团(德国)
    • 利洁时集团股份有限公司(英国)
    • Metrex Research LLC(美国)
    • 美诺集团(德国)
    • Pal International(英国)
    • Melag Medizintechnik GmbH & Co. KG(德国)
    • 康泰克公司(美国)
    • 梅达尔坎(希腊)
    • Systec GmbH(德国)
    • CBMSrl 医疗设备(义大利)
    • 美国大陆设备公司
    • BGS Beta-Gamma-Service GmbH & Co. KG(德国)

结论与建议

简介目录
Product Code: SQMIG35A2598

Hospital-Acquired Infection Control Market size was valued at USD 32.62 Billion in 2024 and is poised to grow from USD 35 Billion in 2025 to USD 61.5 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The Hospital Acquired Infection (HAI) control market is witnessing significant growth driven by increased awareness of the importance of preventing cross-infections and the high incidence of infectious diseases in healthcare settings. Government support for infection control initiatives also plays a crucial role in enhancing market dynamics. Strict infection prevention standards and protocols established across diverse healthcare levels foster a culture centered on safety and hygiene. Furthermore, the escalating use of advanced monitoring solutions strengthens this trend, enabling healthcare facilities to implement proactive strategies for effectively preventing and managing HAIs. These combined factors underscore a growing commitment to maintaining patient safety and improving overall health outcomes within hospitals.

Top-down and bottom-up approaches were used to estimate and validate the size of the Hospital-Acquired Infection Control market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Hospital-Acquired Infection Control Market Segments Analysis

Global Hospital-Acquired Infection Control Market is segmented by Product, Application, Technology, Disease, End User and region. Based on Product, the market is segmented into Protective Barrier, Sterilization, Disinfectants, Disinfectors, Endoscope Reprocessing Products and Other Infection Control Products. Based on Application, the market is segmented into Disease Testing and Drug-Resistance Testing. Based on Technology, the market is segmented into Phenotypic Methods and Genotypic Methods. Based on Disease, the market is segmented into Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection and Others. Based on End User, the market is segmented into Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers, Nursing Homes & Maternity Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Hospital-Acquired Infection Control Market

The global Hospital-Acquired Infection Control market has seen significant growth driven by the rising number of surgical procedures performed each year, which has reached an impressive volume globally. This surge can be attributed to various factors, including the increasing incidence of health conditions such as obesity and other lifestyle-related diseases, which often require surgical treatment. As more surgeries are conducted, the associated risk of hospital-acquired infections also escalates, highlighting the critical need for effective infection control measures. Consequently, healthcare facilities are increasingly investing in advanced infection prevention solutions to enhance patient safety and improve overall outcomes.

Restraints in the Hospital-Acquired Infection Control Market

The Hospital-Acquired Infection Control market faces a challenge as healthcare providers frequently choose to reprocess reusable medical devices to cut costs and minimize waste. This practice involves a diverse array of instruments, including surgical forceps, endoscopes, and stethoscopes. Despite the financial and environmental benefits, there are ongoing concerns about the safety and effectiveness of these reprocessed instruments. Such apprehensions can lead to hesitancy among healthcare professionals and patients alike, potentially impacting the overall adoption of infection control measures within medical facilities. As a result, the perceived risks associated with reprocessing may constrain market growth and innovation in infection prevention strategies.

Market Trends of the Hospital-Acquired Infection Control Market

The market for Hospital-Acquired Infection (HAI) control is witnessing a significant trend towards the reintroduction of ethylene oxide sterilization due to its unparalleled effectiveness, particularly for temperature-sensitive medical instruments. This resurgence is driven by an increasing demand for advanced sterilization methods that maintain the integrity of delicate devices. However, the evolving landscape is marked by a growing awareness surrounding the health risks tied to ethylene oxide exposure, prompting healthcare facilities to adopt improved safety protocols and technologies. As hospitals seek to balance efficacy with safety, innovations in delivery systems and monitoring practices are expected to enhance the appeal and acceptance of ethylene oxide in infection control strategies.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Hospital-Acquired Infection Control Market Size by Product & Services & CAGR (2026-2033)

  • Market Overview
  • Protective Barrier
  • Sterilization
  • Disinfectants
    • Product
    • Hand Disinfectants
    • Surface Disinfectants
    • Skin Disinfectants
    • Instrument Disinfectants
    • Formulation
    • Liquid Disinfectants
    • Disinfectant Wipes
    • Disinfectant Sprays
  • Disinfectors
  • Endoscope Reprocessing Products
  • Other Infection Control Products

Global Hospital-Acquired Infection Control Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Disease Testing
  • Drug-Resistance Testing

Global Hospital-Acquired Infection Control Market Size by Technology & CAGR (2026-2033)

  • Market Overview
  • Phenotypic Methods
  • Genotypic Methods

Global Hospital-Acquired Infection Control Market Size by Disease & CAGR (2026-2033)

  • Market Overview
  • Hospital Acquired Pneumonia
  • Bloodstream Infections
  • Surgical Site Infections
  • Gastrointestinal Infections
  • Urinary Tract Infection
  • Others

Global Hospital-Acquired Infection Control Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals & ICUs
  • Ambulatory Surgical & Diagnostic Centers
  • Nursing Homes & Maternity Centers
  • Others

Global Hospital-Acquired Infection Control Market Size & CAGR (2026-2033)

  • North America (Product & Services, Application, Technology, Disease, End User)
    • US
    • Canada
  • Europe (Product & Services, Application, Technology, Disease, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product & Services, Application, Technology, Disease, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product & Services, Application, Technology, Disease, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product & Services, Application, Technology, Disease, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • 3M Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ecolab Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advanced Sterilization Products (ASP) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Belimed AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Matachana Group (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MMM Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reckitt Benckiser Group plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Metrex Research LLC (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Miele Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pal International (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Melag Medizintechnik GmbH & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Contec, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MEDALKAN (Greece)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Systec GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • C.B.M. S.r.l. Medical Equipment (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Continental Equipment Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGS Beta-Gamma-Service GmbH & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations